Supporting the Demands of Transplant-Associated Molecular Testing

Viruses such as Adenovirus, CMV, BK, and JCV are frequently monitored in transplant-associated testing protocols. Literature continues to highlight the importance of early viral detection in the transplant setting.

Yet many testing solutions cater to high-throughput labs or narrowly defined panels. That’s where ELITechGroup MDx – A Bruker Company, helps bridge the gap. We understand that mid-volume molecular labs face unique operational challenges—including limited resources and high assay complexity.

That’s why we offer transplant-focused Analyte Specific Reagents (ASRs§) developed to support flexible workflows and assay customization for mid-volume molecular labs.

 

§Analyte Specific Reagent. Analytical and performance characteristics are not established.

How We Support Molecular Labs Like Yours

We understand what’s at stake – timely detection of transplant-associated viral targets can be critical. Our transplant-focused ASR§ portfolio is designed to support the needs of mid-volume molecular labs without compromising flexibility or workflow efficiency.

  • Broaden your coverage: ASRs§ available for BK virus, CMV, EBV, HHV-6, JCV, and VZV
  • Expand your targets: Analyte specific reagents for Adenovirus, designed to support detection across all 7 species and over 100 genotypes
  • Simplify validation: Intended for use in CLIA-certified labs developing laboratory-developed tests (LDTs)

§Analyte Specific Reagent. Analytical and performance characteristics are not established.

Trusted By High-Complexity Labs Nationwide

At ELITechGroup MDx — A Bruker Company, we are leaders in providing innovative diagnostic solutions to laboratories around the world. With decades of experience in the industry, our mission is to empower labs with the tools and knowledge they need to develop accurate, reliable and timely molecular diagnostics. We are committed to supporting our partners through every regulatory change, ensuring that patient care remains at the forefront of everything we do.

Questions?

Name(Required)